Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Ann Thorac Surg ; 2024 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-39209091

RESUMEN

BACKGROUND: Sex-disparities remain pervasive across most cardiovascular diseases and continue to demonstrate significantly worse early and late outcomes for women, especially after surgical repair. This study aims to investigate outcomes of mitral valve (MV) repair by sex and identify opportunities for improvement. METHODS: A single-centre retrospective analysis of consecutive patients undergoing MV repair was conducted, from May 2008 - February 2023. In-hospital and long-term outcomes, including survival and symptomatic disease recurrence (sMR) were examined by sex. Adjusted outcome analysis was performed using inverse-probability treatment weighting (IPTW). RESULTS: In total, 490 patients underwent MV repair (Median age 65 years [IQR 57-73 years] sternotomy n=128 [26%], minimally-invasive n=362 [74%]), including 343 males and 147 females. Median follow-up time was 5.4 years, with an interquartile range of 3.1 to 8.4 years. IPTW-adjusted 30-day outcomes for female versus males, including death (1.4% vs 0.6%, p=0.59) and MACE (8.2% vs 7.6%, p=0.81), were not significantly different. Survival for females vs males after mitral valve repair was 94.9% vs 98.0% at 2 years, 91.4% vs 97.8% at 4 years and 87.2 % vs 88.7% at 8 years (HR 0.52 [0.19-1.44]). Both unadjusted and IPTW-adjusted Cox-regression hazard ratios for survival and freedom from sMR demonstrated no significant difference between sexes at long-term follow up. CONCLUSIONS: These contemporary results are encouraging and suggest that a critical "bridging of the gap" between sexes is possible with comprehensive efforts including earlier detection and awareness and improved surgical techniques, though other factors may be important to explore further.

3.
Indian J Thorac Cardiovasc Surg ; 40(2): 177-183, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38389766

RESUMEN

Purpose: Bleeding is a major complication of patients requiring extracorporeal membrane oxygenation (ECMO). Several risk factors have been identified; however, there remains a paucity of evidence for optimal management of anticoagulation and bleeding in ECMO patients. Methods: A total of 255 patients required ECMO from January 1996 to December 2021 at a single institution. The Bleeding Academic Research Consortium (BARC) Score was used for defining actionable bleeding. Univariate and multivariate testing were used for outcome analysis. Kaplan-Meier survival curves were plotted for time-to-event analysis. Results: Of the 255 patients, 147 patients had no actionable bleeding complications, while 108 had at least one actionable bleeding complication. Duration of support (p<0.001) and total number of transfusions (p<0.001) differed between the two groups significantly, with no significant difference in survival to discharge (p=0.894). On multivariate regression, significant predictors for actionable bleeding complications included diabetes (OR 2.01, p=0.03), precannulation hematocrit (OR 0.97, p<0.001), length of support (OR 1.00, p<0.001), use of warfarin (OR 2.28, p=0.03), and post-cardiotomy indication for ECMO (OR 0.77, p=0.02). The median time to first actionable bleeding complication after cannulation was 141.2 h. When stratified by indication for ECMO or type of ECMO circuit, there was a significant difference in time to first actionable bleeding complication (p=0.001, p=0.018). Conclusions: Indication for ECMO and type of ECMO circuit both are predictive of timing to first actionable bleeding complication in our study. Further data are needed to reliably establish individualized anticoagulation strategies and bleeding management based on indication and circuit setup. Supplementary Information: The online version contains supplementary material available at 10.1007/s12055-023-01601-9.

4.
J Cardiothorac Surg ; 18(1): 338, 2023 Nov 22.
Artículo en Inglés | MEDLINE | ID: mdl-37990270

RESUMEN

BACKGROUND: Re-opening the chest is an unwanted and potentially morbid complication after open heart surgery, most commonly required for refractory bleeding or tamponade. In this report, we present a unique case of a postoperative coronary artery bypass patient, demonstrating clinical features of cardiac tamponade of the right atrium and ventricle with inconclusive findings on imaging. CASE PRESENTATION: A 62 year-old male presented to hospital with exertional angina and a coronary angiogram found severe three-vessel coronary artery disease with preserved left ventricular function. He underwent an uncomplicated triple coronary artery bypass surgery. Over the following hours in the cardiac intensive care unit, the patient had a climbing serum lactate level and increasing vasopressor requirements. On investigations, there was evidence of compression of the right heart. The patient was taken back to the operating room where very little clot or bleeding was identified, rather there was significant amounts of mediastinal fat surrounding the heart which was subsequently resected with wide margins. The patient had complete resolution of their symptoms and an uncomplicated postoperative course thereafter. CONCLUSIONS: To our knowledge, this case is the first reported occurrence of cardiac constriction from excessive mediastinal fat after open heart surgery. Identifying patients at high-risk for excessive pericardial fat, as well as considering alternative modalities of imaging appear to be the main stay in diagnosis at this point. Current treatment is a mediastinal lipectomy with wide margins, avoiding injury to surrounding structures such as the phrenic nerve and innominate vein. Future study might consider the value of prophylactic mediastinal lipectomy at time of surgery, and methods to improve detection with current and future imaging modalities.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos , Taponamiento Cardíaco , Lipectomía , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Cardíacos/efectos adversos , Taponamiento Cardíaco/etiología , Taponamiento Cardíaco/cirugía , Puente de Arteria Coronaria/efectos adversos , Pericardio/cirugía
6.
CJC Pediatr Congenit Heart Dis ; 1(4): 200-202, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37969933

RESUMEN

The arterial switch operation is the gold-standard treatment for dextro-transposition of the great arteries. Long-term follow-up data are beginning to reveal its natural history and associated late complications, including various reoperations for those complications. Given the unique anatomy and the increasing longevity of these patients, there is a need for effective surgical repair options to address aneurysmal and degenerative changes in both neoaortic and pulmonic roots. Thereby, we describe our technique and the novel considerations for prosthetic choice with reconstruction of both the neoaortic root and pulmonary artery, with satisfactory postoperative results.


La détransposition artérielle constitue le traitement de référence dans les cas de dextro-transposition des gros vaisseaux. De nouvelles données, issues du suivi à long terme, nous permettent de mieux comprendre l'évolution naturelle à la suite de cette intervention et les complications tardives qui y sont associées, y compris les diverses interventions à réaliser pour les corriger. Étant donné les caractéristiques anatomiques uniques de ces patients et l'augmentation de leur espérance de vie, il est nécessaire de proposer des options efficaces de réparations chirurgicales pour remédier aux changements anévrismaux et dégénératifs des racines néoaortique et pulmonaire. Ainsi, nous décrivons la technique que nous avons utilisée et les nouveaux éléments qui entrent en ligne de compte dans le choix d'une prothèse pour une reconstruction de la racine néoaortique et de l'artère pulmonaire, avec des résultats postopératoires jugés satisfaisants.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA